Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grace Opens GMP Release QC Lab at Oregon Facility | Contract Pharma
Breaking News

Grace Opens GMP Release QC Lab at Oregon Facility

To support pharmaceutical intermediates manufacturing

W. R. Grace & Co. has opened a good manufacturing practice (GMP) release quality control (QC) lab at its fine chemicals manufacturing facility located in Albany, OR, expanding support for GMP manufacturing and release for the pharmaceutical and dietary-related industries.

The new lab’s capabilities will enable the site to validate analytical methods and perform GMP release of starting materials and advanced intermediates. The lab already has passed customer inspections and completed method validation and GMP release of commercial intermediates for major pharmaceutical companies. The analytical equipment in the lab includes HPLC, UPLC, GC-MS, and GC-MS with headspace, along with other common analytical equipment.

“Grace continues to invest and expand our capabilities in custom manufacturing of regulatory materials,” said Brett Reynolds, global business director, fine chemicals, W.R. Grace. “This higher level GMP manufacturing expands our portfolio of products and services to the pharmaceutical and related industries.”

Grace acquired the Albany facility from Synthetech in 2010. The Albany site’s operations team has more than 30 years of custom manufacturing experience in multi-step organic, organometallic, and chiral chemistry, and integrated kilos-to-tons GMP production.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters